BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29187589)

  • 1. STAT5B: A Differential Regulator of the Life and Death of CD4
    Majri SS; Fritz JM; Villarino AV; Zheng L; Kanellopoulou C; Chaigne-Delalande B; Grönholm J; Niemela JE; Afzali B; Biancalana M; Pittaluga S; Sun A; Cohen JL; Holland SM; O'Shea JJ; Uzel G; Lenardo MJ
    J Immunol; 2018 Jan; 200(1):110-118. PubMed ID: 29187589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive activation of STAT5 supersedes the requirement for cytokine and TCR engagement of CD4+ T cells in steady-state homeostasis.
    Taylor DK; Walsh PT; LaRosa DF; Zhang J; Burchill MA; Farrar MA; Turka LA
    J Immunol; 2006 Aug; 177(4):2216-23. PubMed ID: 16887981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis.
    Murawski MR; Litherland SA; Clare-Salzler MJ; Davoodi-Semiromi A
    Ann N Y Acad Sci; 2006 Oct; 1079():198-204. PubMed ID: 17130555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FRA2 is a STAT5 target gene regulated by IL-2 in human CD4 T cells.
    Rani A; Greenlaw R; Runglall M; Jurcevic S; John S
    PLoS One; 2014; 9(2):e90370. PubMed ID: 24587342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions.
    Villarino A; Laurence A; Robinson GW; Bonelli M; Dema B; Afzali B; Shih HY; Sun HW; Brooks SR; Hennighausen L; Kanno Y; O'Shea JJ
    Elife; 2016 Mar; 5():. PubMed ID: 26999798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial STAT5 signaling is sufficient for CD4
    Fleury M; Vazquez-Mateo C; Hernandez-Escalante J; Dooms H
    Cytokine; 2022 Feb; 150():155770. PubMed ID: 34839177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for Stat5 in CD8+ T cell homeostasis.
    Kelly J; Spolski R; Imada K; Bollenbacher J; Lee S; Leonard WJ
    J Immunol; 2003 Jan; 170(1):210-7. PubMed ID: 12496402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-7/STAT5 cytokine signaling pathway is essential but insufficient for maintenance of naive CD4 T cell survival in peripheral lymphoid organs.
    Seki Y; Yang J; Okamoto M; Tanaka S; Goitsuka R; Farrar MA; Kubo M
    J Immunol; 2007 Jan; 178(1):262-70. PubMed ID: 17182563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique features of naive CD8+ T cell activation by IL-2.
    Cho JH; Kim HO; Kim KS; Yang DH; Surh CD; Sprent J
    J Immunol; 2013 Dec; 191(11):5559-73. PubMed ID: 24166977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells.
    Riou C; Yassine-Diab B; Van grevenynghe J; Somogyi R; Greller LD; Gagnon D; Gimmig S; Wilkinson P; Shi Y; Cameron MJ; Campos-Gonzalez R; Balderas RS; Kelvin D; Sekaly RP; Haddad EK
    J Exp Med; 2007 Jan; 204(1):79-91. PubMed ID: 17190839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment.
    Goetz CA; Harmon IR; O'Neil JJ; Burchill MA; Johanns TM; Farrar MA
    J Immunol; 2005 Jun; 174(12):7753-63. PubMed ID: 15944278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: Decreased accumulation and regulatory function of CD4+ CD25(high) T cells in human STAT5b deficiency.
    Cohen AC; Nadeau KC; Tu W; Hwa V; Dionis K; Bezrodnik L; Teper A; Gaillard M; Heinrich J; Krensky AM; Rosenfeld RG; Lewis DB
    J Immunol; 2006 Sep; 177(5):2770-4. PubMed ID: 16920911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells.
    Burchill MA; Goetz CA; Prlic M; O'Neil JJ; Harmon IR; Bensinger SJ; Turka LA; Brennan P; Jameson SC; Farrar MA
    J Immunol; 2003 Dec; 171(11):5853-64. PubMed ID: 14634095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homeostasis of naive and memory CD4+ T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis.
    Jaleco S; Swainson L; Dardalhon V; Burjanadze M; Kinet S; Taylor N
    J Immunol; 2003 Jul; 171(1):61-8. PubMed ID: 12816983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.
    Nieborowska-Skorska M; Wasik MA; Slupianek A; Salomoni P; Kitamura T; Calabretta B; Skorski T
    J Exp Med; 1999 Apr; 189(8):1229-42. PubMed ID: 10209040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FcRγ promotes T cell apoptosis in Fas-deficient mice.
    Juvet SC; Thomson CW; Kim EY; Joe B; Adeyi O; Zhang L
    J Autoimmun; 2013 May; 42():80-93. PubMed ID: 23313147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for STAT5A/B in protection of peripheral T-lymphocytes from postactivation apoptosis: insights from gene expression profiling.
    Gatzka M; Piekorz R; Moriggl R; Rawlings J; Ihle JN
    Cytokine; 2006 May; 34(3-4):143-54. PubMed ID: 16757175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 activates STAT5 in T cells.
    Tormo AJ; Letellier MC; Sharma M; Elson G; Crabé S; Gauchat JF
    Cytokine; 2012 Nov; 60(2):575-82. PubMed ID: 22854263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic background influences Th cell differentiation by controlling the capacity for IL-2-induced IL-4 production by naive CD4+ T cells.
    Yagi J; Arimura Y; Takatori H; Nakajima H; Iwamoto I; Uchiyama T
    Int Immunol; 2006 Dec; 18(12):1681-90. PubMed ID: 17035345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT5B restrains human B-cell differentiation to maintain humoral immune homeostasis.
    Pelham SJ; Caldirola MS; Avery DT; Mackie J; Rao G; Gothe F; Peters TJ; Guerin A; Neumann D; Vokurkova D; Hwa V; Zhang W; Lyu SC; Chang I; Manohar M; Nadeau KC; Gaillard MI; Bezrodnik L; Iotova V; Zwirner NW; Gutierrez M; Al-Herz W; Goodnow CC; Vargas-Hernández A; Forbes Satter LR; Hambleton S; Deenick EK; Ma CS; Tangye SG
    J Allergy Clin Immunol; 2022 Oct; 150(4):931-946. PubMed ID: 35469842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.